Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

324

Participants

Timeline

Start Date

March 31, 1996

Primary Completion Date

October 31, 2007

Conditions
Ovarian CancerPrimary Peritoneal Cavity Cancer
Interventions
DRUG

cisplatin

DRUG

paclitaxel

Trial Locations (52)

10021

Memorial Sloan-Kettering Cancer Center, New York

11203

State University of New York Health Science Center at Brooklyn, Brooklyn

12208

Cancer Center of Albany Medical Center, Albany

14642

University of Rochester Cancer Center, Rochester

17033

Milton S. Hershey Medical Center, Hershey

19001

Abington Memorial Hospital, Abington

19104

University of Pennsylvania Cancer Center, Philadelphia

19107

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia

Pennsylvania Hospital, Philadelphia

19111

Fox Chase Cancer Center, Philadelphia

20007

Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington D.C.

21287

Johns Hopkins Oncology Center, Baltimore

22908

Cancer Center, University of Virginia HSC, Charlottesville

27710

Duke Comprehensive Cancer Center, Durham

29303

CCOP - Upstate Carolina, Spartanburg

30322

Emory University Hospital - Atlanta, Atlanta

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

35294

University of Alabama Comprehensive Cancer Center, Birmingham

38117

CCOP - Baptist Cancer Institute, Memphis

43210

Arthur G. James Cancer Hospital - Ohio State University, Columbus

44195

Cleveland Clinic Cancer Center, Cleveland

45219

Barrett Cancer Center, The University Hospital, Cincinnati

48106

CCOP - Ann Arbor Regional, Ann Arbor

48201

Barbara Ann Karmanos Cancer Institute, Detroit

52242

University of Iowa Hospitals and Clinics, Iowa City

55455

University of Minnesota Cancer Center, Minneapolis

60612

Rush-Presbyterian-St. Luke's Medical Center, Chicago

60637

University of Chicago Cancer Research Center, Chicago

62526

CCOP - Central Illinois, Decatur

63110

Washington University School of Medicine, St Louis

64131

CCOP - Kansas City, Kansas City

73190

University of Oklahoma College of Medicine, Oklahoma City

77030

University of Texas - MD Anderson Cancer Center, Houston

80262

University of Colorado Cancer Center, Denver

92868

Chao Family Comprehensive Cancer Center, Orange

94304

Women's Cancer Center, Palo Alto

96813

MBCCOP - Hawaii, Honolulu

98405

Tacoma General Hospital, Tacoma

90033-0800

USC/Norris Comprehensive Cancer Center, Los Angeles

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

20307-5000

Walter Reed Army Medical Center, Washington D.C.

46202-5265

Indiana University Cancer Center, Indianapolis

40536-0084

Albert B. Chandler Medical Center, University of Kentucky, Lexington

01655

University of Massachusetts Memorial Medical Center, Worcester

39216-4505

University of Mississippi Medical Center, Jackson

08103

Cooper Hospital/University Medical Center, Camden

27599-7295

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill

27157-1082

Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem

44106-5065

Ireland Cancer Center, Cleveland

29425-0721

Medical University of South Carolina, Charleston

75235-9154

Simmons Cancer Center - Dallas, Dallas

98195-6043

University of Washington Medical Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00002717 - Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter